CortControl
Science-Based Nutraceuticals
616223894.jpg

blog

CortControl Blog

​As Patients Consider New Personalized Treatment Options, Health Care Providers Should Too

BY JAMES DANIELS, CEO, CORTCONTROL LLC

Like everything dynamic, health care treatment is evolving rapidly. And today, more and more consumers are becoming intrigued by an approach to health care called “integrative medicine,” which offers new options—and opportunities—for the improved personalized treatment for patients. This is not something radically new or different. In fact, the premise behind it is about as basic and sensible as ideas come. The thinking is that the best health care solutions might not necessarily be one-dimensional, as in “Take this pill three times a day.” Instead, perhaps it might be a specific combination of drugs and complementary remedies such as diet, exercise, vitamins, and/or FDA accepted specialty nutraceuticals. 

What Is a Specialty Nutraceutical?

For some, of course, the term “specialty nutraceutical” does not have the familiar ring of “exercise” or “vitamins.”  Still unfamiliar even to many doctors and others in health care, these are dietary products developed specifically for support of specific structures or physical functions. They are not substitutes for drugs and other traditional medical treatments but rather part of this integrative approach to safely and effectively support health issues. 

To learn more, check out the Dietary Supplements Guidance Documents and Regulatory Information page on the FDA’s website.

Doctors, Pharmaceutical Companies Slow to Adapt

While interest in specialty nutraceuticals grows among consumers, however, many doctors and pharmaceutical companies remain resistant to them. In one recent American Hospital Association survey, for example, 44% of respondents listed “physician resistance” as one of the three main barriers to adopting integrative medicine programs that may include specialty nutraceuticals in the mix. Likewise, some pharmaceutical companies have seen specialty supplements as a threat to their businesses rather than a potential revenue opportunity to capitalize on.

This is a shame because, just as specialty nutraceuticals represent a promising new option for doctors and patients, they represent a major market opportunity for these companies. Solid growth is expected for specialty nutraceuticals in the next few years—if pharmaceutical companies pursued this opportunity more aggressively—this growth could be much higher.

How Can Pharmaceutical Companies Benefit?   

They can:

  • Acknowledge the growing consumer interest in, and become advocates for, personalized treatment.
  • View specialty nutraceuticals as enhancements to their product lines and a clear competitive edge.
  • License patented, FDA-accepted specialty supplements to manufacture and distribute to their core markets. (Because these foods are already FDA-accepted, R&D costs are minimal and time to market is rapid.)
  • Manufacture and offer products with substantial profit margins.
  • Help physicians and clinics improve their treatment protocols and better differentiate themselves. 

Personalized treatment is an idea whose time has come, and medical foods are an integral part of this new paradigm. For doctors who want to provide new options for patients, and for pharmaceutical companies that want to strengthen their competitive edge, responding to this growing consumer demand makes absolute sense.

James Daniels is the CEO of CortControl, which develops and markets GlutrasolTM, a family of patented specialty supplements supporting fertility, immune health and other health concerns.  

Laura CoxComment